DUBLIN--(BUSINESS WIRE)--The "Cold Pain Therapy Market by Product (OTC (Gels, Sprays, Patches, Cold Packs, Wraps, Pads, and Roll-Ons), Prescription-Based (Motorized, Non-Motorized Devices), Applications - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global cold pain therapy market is projected to reach USD 2.12 billion by 2023 from USD 1.69 billion in 2018, at a CAGR of 4.6%
The increasing incidence of sports injuries and rising emphasis on exercise and gym activities, growing number of hip and knee surgeries across the globe, and growing need for safer pain management modalities as opposed to oral drug therapy are expected to drive the demand for cold pain therapy products during the study period. On the other hand, lack of reimbursement and high usage of low-priced analgesic pills for immediate pain relief across the globe may limit market growth during the forecast period.
The OTC products segment accounted for the larger share of the global cold pain therapy market in 2017. This can be attributed to factors such as high patient preference for topical pharmaceuticals compared to oral medications owing to its lower side effects, fast pain relief, and convenience in use.
The market is segmented into musculoskeletal disorders, post-operative therapy, sports medicine, and post-trauma therapy on the basis of application. In 2017, the musculoskeletal disorders segment is growing at the highest CAGR during the forecast period. The increasing incidence of arthritis, osteoarthritis, back pain, and joint pain; rising geriatric population; increasing trend of self care; and the growing preference for topical analgesics to manage musculoskeletal pain are some of the major factors driving the growth of this market segment.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Cold Pain Therapy Market, By Product
7 Cold Pain Therapy Market, By Application
8 Cold Pain Therapy Market, By Region
9 Competitive Landscape
10 Company Profiles
- Custom Ice
- DJO Finance
- Hisamitsu Pharmaceutical
- Johnson & Johnson
- Medline Industries
- Performance Health
- Rohto Pharmaceutical
- Romsons Group of Industries
- Unexo Life Sciences
For more information about this report visit https://www.researchandmarkets.com/research/9tm62k/cold_pain_therapy?w=4